EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RAI1 transcription factor activity is impaired in mutants associated with Smith-Magenis Syndrome



RAI1 transcription factor activity is impaired in mutants associated with Smith-Magenis Syndrome



Plos One 7(9): E45155-E45155



Smith-Magenis Syndrome (SMS) is a complex genomic disorder mostly caused by the haploinsufficiency of the Retinoic Acid Induced 1 gene (RAI1), located in the chromosomal region 17p11.2. In a subset of SMS patients, heterozygous mutations in RAI1 are found. Here we investigate the molecular properties of these mutated forms and their relationship with the resulting phenotype. We compared the clinical phenotype of SMS patients carrying a mutation in RAI1 coding region either in the N-terminal or the C-terminal half of the protein and no significant differences were found. In order to study the molecular mechanism related to these two groups of RAI1 mutations first we analyzed those mutations that result in the truncated protein corresponding to the N-terminal half of RAI1 finding that they have cytoplasmic localization (in contrast to full length RAI1) and no ability to activate the transcription through an endogenous target: the BDNF enhancer. Similar results were found in lymphoblastoid cells derived from a SMS patient carrying RAI1 c.3103insC, where both mutant and wild type products of RAI1 were detected. The wild type form of RAI1 was found in the chromatin bound and nuclear matrix subcellular fractions while the mutant product was mainly cytoplasmic. In addition, missense mutations at the C-terminal half of RAI1 presented a correct nuclear localization but no activation of the endogenous target. Our results showed for the first time a correlation between RAI1 mutations and abnormal protein function plus they suggest that a reduction of total RAI1 transcription factor activity is at the heart of the SMS clinical presentation.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333044

Download citation: RISBibTeXText

PMID: 23028815

DOI: 10.1371/journal.pone.0045155



Related references

A Rare De Novo RAI1 Gene Mutation Affecting BDNF-Enhancer-Driven Transcription Activity Associated with Autism and Atypical Smith-Magenis Syndrome Presentation. Biology 7(2): -, 2018

Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity. American Journal of Human Genetics 90(6): 941-949, 2012

Mutations in RAI1 associated with Smith-Magenis syndrome. Nature Genetics 33(4): 466-468, April, 2003

RAI1 gene mutations: mechanisms of Smith-Magenis syndrome. Application of Clinical Genetics 10: 85-94, 2017

Characterization of Rai1 as a candidate gene for Smith-Magenis syndrome. American Journal of Human Genetics 71(4 Supplement): 337, October, 2002

Mutations of RAI1, a PHD-containing protein, in nondeletion patients with Smith-Magenis syndrome. Human Genetics 115(6): 515-524, 2004

RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions. Journal of Medical Genetics 42(11): 820-828, 2005

RAI1 mutations associated with Smith-Magenis syndrome in individuals with no detectable 17p112 deletion. Genetics in Medicine 5(3): 201, May-June, 2003

RAI1 is a novel polyglutamine encoding gene that is deleted in Smith-Magenis syndrome patients. Gene (Amsterdam) 270(1-2): 69-76, 2001

Diagnostic FISH probes for del(17)(p11.2p11.2) associated with Smith-Magenis syndrome should contain the RAI1 gene. American Journal of Medical Genetics. Part A 132a(3): 278-282, 2005

Molecular and Neural Functions of Rai1, the Causal Gene for Smith-Magenis Syndrome. Neuron 92(2): 392-406, 2016

Identification of Nine New RAI1-Truncating Mutations in Smith-Magenis Syndrome Patients without 17p11.2 Deletions. Molecular Syndromology 5(2): 57-64, 2014

RAI1 point mutations, CAG repeat variation, and SNP analysis in non-deletion Smith-Magenis syndrome. American Journal of Medical Genetics. Part A 140(22): 2454-2463, 2006

Circadian abnormalities in mouse models of Smith-Magenis syndrome: evidence for involvement of RAI1. American Journal of Medical Genetics. Part A 161a(7): 1561-1568, 2014

Diagnosing Smith-Magenis syndrome and duplication 17p11.2 syndrome by RAI1 gene copy number variation using quantitative real-time PCR. Genetic Testing 12(1): 67-73, 2008